In vivo transfection of a cis element 'decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity

被引:14
作者
Sumi, K
Yokozeki, H
Wu, MH
Satoh, T
Kaneda, Y
Takeda, K
Akira, S
Nishioka, K
机构
[1] Tokyo Med & Dent Univ, Postgrad Sch, Dept Environm Immunodermatol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Osaka Univ, Sch Med, Dept Gene Therapy, Osaka, Japan
[3] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Japan
关键词
contact hypersensitivity; atopic dermatitis; STAT6; decoy; Th2; cytokine;
D O I
10.1038/sj.gt.3302345
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We herein demonstrate that STAT6 plays an important role in the induction of not only acute contact hypersensitivity (CHS), but also chronic CHS in a mouse model using STAT6-deficient ( STAT6 (/)) mice. We, therefore, determine whether synthetic double-stranded DNA with a high affinity for STAT6 can be introduced in vivo as a decoy cis element to bind the transcriptional factor and block the induction of not only acute CHS but also chronic CHS. Treatment by the transfection of STAT6 decoy oligodeoxynucleotides (ODN), after the induction of 2,4,6-trinitrochlorobenzene or other haptens had a significant inhibitory effect on the induction of both acute CHS and chronic CHS. We thus examined the mechanism of the in vivo effect of the transfection of STAT6 decoy ODN in both acute and chronic CHS. In the histological analysis, the infiltration of eosinophils and degranulated mast cells, and the production of IL-4, IL-6 and eotaxin, but not IFN-gamma in the extracts from challenged skin significantly decreased by the transfection of STAT6 decoy ODN. We herein report the first successful in vivo transfer of STAT6 decoy ODN to inhibit acute and chronic CHS, thus providing a new therapeutic strategy not only for the treatment of CHS but also for atopic dermatitis.
引用
收藏
页码:1763 / 1771
页数:9
相关论文
共 35 条
[11]   Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model [J].
Kawamura, I ;
Morishita, R ;
Tomita, N ;
Lacey, E ;
Aketa, M ;
Tsujimoto, S ;
Manda, T ;
Tomoi, M ;
Kida, I ;
Higaki, J ;
Kaneda, Y ;
Shimomura, K ;
Ogihara, T .
GENE THERAPY, 1999, 6 (01) :91-97
[12]   Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice [J].
Kawamura, I ;
Morishita, R ;
Tsujimoto, S ;
Manda, T ;
Tomoi, M ;
Tomita, N ;
Goto, T ;
Ogihara, T ;
Kaneda, Y .
GENE THERAPY, 2001, 8 (12) :905-912
[13]   IMMEDIATE-TYPE HYPERSENSITIVITY RESPONSE FOLLOWED BY A LATE REACTION IS INDUCED BY REPEATED EPICUTANEOUS APPLICATION OF CONTACT SENSITIZING AGENTS IN MICE [J].
KITAGAKI, H ;
FUJISAWA, S ;
WATANABE, K ;
HAYAKAWA, K ;
SHIOHARA, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (06) :749-755
[14]  
Kitagaki H, 1997, J IMMUNOL, V159, P2484
[15]   Role of STAT6 in IgE receptor/FcεRI-mediated late phase allergic responses of mast cells [J].
Malaviya, R ;
Uckun, FM .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :421-426
[16]   NF-KAPPA-B - A FAMILY OF INDUCIBLE AND DIFFERENTIALLY EXPRESSED ENHANCER-BINDING PROTEINS IN HUMAN T-CELLS [J].
MOLITOR, JA ;
WALKER, WH ;
DOERRE, S ;
BALLARD, DW ;
GREENE, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :10028-10032
[17]   In vivo transfection of cis element ''decoy'' against nuclear factor-kappa B binding site prevents myocardial infarction [J].
Morishita, R ;
Sugimoto, T ;
Aoki, M ;
Kida, I ;
Tomita, N ;
Moriguchi, A ;
Maeda, K ;
Sawa, Y ;
Kaneda, Y ;
Higaki, J ;
Ogihara, T .
NATURE MEDICINE, 1997, 3 (08) :894-899
[18]   Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease [J].
Morishita, R ;
Higaki, J ;
Tomita, N ;
Ogihara, T .
CIRCULATION RESEARCH, 1998, 82 (10) :1023-1028
[19]  
Morishita Ryuichi, 2000, Current Drug Targets, V1, P15, DOI 10.2174/1389450003349344
[20]  
MULLER KM, 1993, J IMMUNOL, V150, P5576